Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

685
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
685
Drug Regulation01:25

Drug Regulation

2.9K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.9K
Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

363
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
363
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

1.4K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.4K
Pharmacovigilance01:19

Pharmacovigilance

2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
Global Regulatory Systems01:28

Global Regulatory Systems

941
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
941

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

WHO prequalification of medicines at 25: Celebrating a unique achievement in a changing landscape.

British journal of clinical pharmacology·2026
Same author

The World Health Organization Coalition of Interested Parties Network: a unified and coordinated approach to regulatory system strengthening.

Frontiers in medicine·2026
Same author

TRIPS flexibilities help change policy and practice to increase access to medicines: evidence from 2001 to 2024.

BMJ global health·2026
Same author

Better engagement, better evidence: working in partnership with patients, the public, and communities in clinical trials with involvement and good participatory practice.

The Lancet. Global health·2025
Same author

Real-World Data and Real-World Evidence in Regulatory Decision Making: Report Summary From the Council for International Organizations of Medical Sciences (CIOMS) Working Group XIII.

Pharmacoepidemiology and drug safety·2025
Same author

Keeping ethical pace with medical research: the 10th revision of the Declaration of Helsinki.

BMJ (Clinical research ed.)·2025

Related Experiment Video

Updated: Apr 22, 2026

Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application
04:24

Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application

Published on: June 16, 2023

2.6K

Regulatory framework for access to safe, effective quality medicines.

Lembit Rägo1, Hiiti Sillo, Ellen 't Hoen

  • 1Department of Essential Medicines and Health Products, World Health Organization, Geneva, Switzerland. ragol@who.int.

Antiviral Therapy
|October 14, 2014
PubMed
Summary

National medicines regulatory authorities protect patients from substandard medicines. Global disparities in regulatory capacity hinder access to quality pharmaceuticals, necessitating international collaboration for consistent standards.

More Related Videos

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

4.3K
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

19.2K

Related Experiment Videos

Last Updated: Apr 22, 2026

Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application
04:24

Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application

Published on: June 16, 2023

2.6K
Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

4.3K
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

19.2K

Area of Science:

  • Pharmaceutical science
  • Public health
  • Regulatory affairs

Background:

  • Substandard medicines pose significant risks, exceeding the harm of no treatment.
  • Global disparities in regulatory capacity limit patient access to pharmaceutical advancements.
  • National medicines regulatory authorities are crucial for patient protection.

Purpose of the Study:

  • To describe key regulatory functions in assuring medicine quality, safety, and efficacy.
  • To examine the application of these functions across diverse environments.
  • To highlight initiatives promoting access to quality medicines and fostering global standards.

Main Methods:

  • Review of regulatory functions for medicine quality, safety, and efficacy.
  • Analysis of regulatory capacity disparities worldwide.
  • Case studies of initiatives improving medicine access and quality.

Main Results:

  • Significant global disparities exist in the capacity of medicines regulatory authorities.
  • Various regulatory functions are essential for ensuring pharmaceutical product integrity.
  • Initiatives have successfully increased access to quality medicines in many regions.

Conclusions:

  • Strengthening regulatory capacity globally is vital for patient safety.
  • International collaboration is key to achieving uniform, stringent quality standards for pharmaceuticals worldwide.
  • Ensuring access to safe and effective medicines requires robust and harmonized regulatory frameworks.